Oral health education (advice and training) showed no clear difference in leaving the study early compared with standard care (oral health advice not specifically emphasised beyond… (moderate certainty).
Motivational interview plus oral health education showed no clear difference in leaving the study early compared with oral health education (moderate certainty).
Monitoring (any means of observation, supervision, keeping under… showed no clear difference in leaving the study early compared with no monitoring (moderate certainty).
The intervention probably leads to higher early mortality (90 days) (moderate certainty).
The review found no eligible studies for this question.
It is very uncertain whether non‐healthcare professional‐led breastfeeding education and support changes early initiation of breastfeeding compared with standard care (very low certainty).
It is very uncertain whether the intervention changes miscarriage rate ‐ Early versus late clomiphene citrate (very low certainty).
The intervention may leads to higher clinical pregnancy ‐ Early versus late clomiphene citrate (low certainty).
It is very uncertain whether VALPROATE + ANTIPSYCHOTICS changes leaving the study early: Acceptability of treatment Leaving the… compared with ANTIPSYCHOTICS + PLACEBO or ANTIPSYCHOTICS alone (very low certainty).
VALPROATE + ANTIPSYCHOTICS showed no clear difference in leaving the study early: Overall tolerability Leaving the study… compared with ANTIPSYCHOTICS + PLACEBO or ANTIPSYCHOTICS alone (low certainty).
Multivitamin plus iron plus folate showed no clear difference in early or late miscarriage ‐ Multivitamin + iron + folic acid versus… compared with iron plus folate (moderate certainty).
Vitamin C and vitamin E showed no clear difference in early or late miscarriage compared with placebo (moderate certainty).
Vitamin A plus iron plus folate showed no clear difference in early or late miscarriage ‐ Vitamin A + iron + folate versus iron +… compared with iron plus folate (low certainty).
RISPERIDONE DEPOT showed no clear difference in leaving the study early: Any reason ‐ short term compared with ORAL RISPERIDONE (moderate certainty).
RISPERIDONE DEPOT probably leads to lower leaving the study early: Any reason ‐ long term compared with ORAL QUETIAPINE (moderate certainty).
It is very uncertain whether RISPERIDONE DEPOT changes leaving the study early: Any reason ‐ long term compared with ORAL ARIPIPRAZOLE (very low certainty).
It is very uncertain whether RISPERIDONE DEPOT changes leaving the study early: Any reason ‐ all doses risperidone depot ‐… compared with PLACEBO (very low certainty).
RISPERIDONE DEPOT may leads to higher leaving the study early: Any reason ‐ long term compared with ORAL OLANZAPINE (low certainty).
RISPERIDONE DEPOT may leads to lower leaving the study early: lack of efficacy ‐ long term compared with ATYPICAL DEPOT ANTIPSYCHOTICS (PALIPERIDONE PALMITATE) (low certainty).